An Australian trial of the drug Tecfidera for MND was reported in 'The Age' newspaper on 21 December. The Australian TEALS (Tecfidera in amyotrophic lateral sclerosis) study is a multi-centre Phase 2 clinical trial to investigate the safety, tolerability and effectiveness of a drug called Tecfidera in people with MND. Tecfidera is currently used to treat relapsing multiple sclerosis (MS) in Australia by slowing down the progression of physical disability of MS.

You can find more information about the Australia TEALS (Tecfidera in amyotrophic lateral sclerosis) Study here

You can read more about Tecfidera for relapsing multiple sclerosis here

Subscribe to news and updates